Micropump Market - By Product (Mechanical Micropumps {Piezoelectric Micropump & Peristaltic Pump}, Non-mechanical Micropumps), By Application (Drug Delivery, In-vitro Diagnostics, Medical Devices), By End-use & Forecast, 2022 - 2030

Micropump Market Size

Micropump Market size surpassed USD 1.5 billion in 2021 and is projected to depict over 19.5% CAGR from 2022 to 2030. The integration of advanced technologies in micropump devices is among the leading factors positively influencing the industry outlook.
 

Key market players have lately been upgrading conventional micropumps, such as rotary vanes, diaphragm pumps, lab-on-chip, ion-driven air flow micropump, etc., to increase their precision and accuracy. The increasing focus on developing cutting-edge medical devices with improved capabilities will transform the market dynamics.
 

The patient-friendly, compact infusion pump is used for continuous subcutaneous drug administration to treat patients with Parkinson’s disease and is available in several European countries. Implantable devices involve several risks and post-procedural complications, such as implant failure, infection, swelling, pain, redness, and pain at the surgical site, factors such as these are projected to negatively impact product adoption.
 

Micropump Market Analysis

Based on the products, the micropump market is bifurcated into mechanical and non-mechanical micropumps. The mechanical micropump segment was worth over USD 1 billion in 2021. These micropumps provide consistent and predictable pumping of various gases and fluids while helping them release precisely at modest flow rates. Mechanical micropumps are utilized for several applications, including targeted medicine administration, microprocessor cooling, and fuel injection, driving their demand through 2030.
 

Regarding the application paradigm, the micropump market from medical devices segment is predicted to expand at over 20.5% CAGR between 2022 and 2030. This is attributed to the accuracy and precision offered by micropumps that support their integration into several medical devices, including conservers, oxygen concentrators, blood pressure machines, infusion pumps, etc. The increasing popularity of lighter, smaller, and quieter medical equipment that offers enhanced portability and ease of use will stimulate the market outlook.
 

In terms of end-user, the hospitals & diagnostic centers segment recorded a valuation of over USD 770 million in 2021. The prevalence of several chronic ailments, such as diabetes and cancer, has accelerated the market trends. Healthcare professionals across these establishments use micropumps for a range of minimally invasive procedures, including pain and wound care management, hormone treatment, blood transportation through artificial hearts, and transdermal insulin delivery, spurring industry statistics.
 

Asia Pacific micropump market is poised to witness a 21.5% CAGR from 2022 to 2030. The increasing investments in the healthcare sector, driven by the rising disease burden and growing health awareness, will augment the regional industry scenario. In addition, the mounting demand for micropumps from several end-use verticals, such as medical, pharmaceutical, micro fluids, and many more, will create optimistic scenarios for the micropump industry across the Asia Pacific region.
 

Micropump Market Share

Notable companies participating in the micropump market include

• Xavitech Micropumps
• Sensile Medical (Gerresheimer AG)
• Antylia Scientific
• Idex Corporation
• Dolomite Microfluids (Blacktrace Holdings Ltd.)
• The Lee Company
• Thomas Gardner Denver (Ingersoll Rand)
• Takasago Electric, Inc.
• Servoflo Corporation
• Bio-chem Fluidics (Halma)

These firms have been focusing on strengthening their market standing through partnerships, collaborations, M&As, and investments to improve their product offerings and lead the way for future innovations.
 

Impact of COVID-19 Pandemic

The market suffered a trivial impact, especially during the initial days of the COVID-19 pandemic, due to supply chain constraints. However, later, on the back of the surging demand for drugs, diagnostic equipment, and medical devices to manage symptoms in COVID positive patients, the industry witnessed unprecedented expansion. R&D investments and biomedical research focused on finding efficient treatment, diagnosis, and preventive therapies to fight against several virus variants emerged as major growth contributors. Moreover, the increasing emphasis on developing advanced drugs and vaccines to mitigate viral transmission will aid industry development.
 

The micropump market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2030 for the following segments:

Click here to Buy Section of this Report

By Product

• Mechanical micropumps
  • Piezoelectric Micropump
  • Peristaltic Micropump
  • Others
• Non-mechanical micropumps

By Application

• Drug Delivery
• In-vitro Diagnostics
• Medical Devices
• Others

By End-use

• Biotechnology & Pharmaceutical Companies
• Hospitals & Diagnostic Centers
• Academic & Research Institutes

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • Saudi Arabia
  • South Africa